CYBERDYNE sees an upgrade to Slightly Positive due to a better fundamental star rating
The general evaluation of CYBERDYNE (JP), a company active in the Medical Equipment industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date April 5, 2022, the closing price was JPY 372.00 and its potential was estimated at JPY 413.08.Cyberdyne Inc. CYBERDYNE, INC. is a Japanese robotics and technology company. The Company's Robot Suit hybrid assistive limb (HAL) products comprise medical robots, which are used for the improvement of physical function of patients in the medical and health care fields; personal care robots, which are used as life support and health training equipment for independent movement support in the nursing care and welfare fields, and work support robots. HAL Therapy is the medical service with Robot Suit HAL to provide medical treatments for functional improvement of patients with cerebral, nervous and muscle disorders including spinal cord injury and cerebral embolism. HAL FIT is a scientific fitness training, in which the wearer in Robot Suit HAL performs leg exercise, standing-up, sitting-down and gait training, in accordance with his or her will. ROBO CARE is a service that provides the motivating and comfortable training courses, for instance Robot Fitness HAL FIT 1 as a main training course.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.